SCHEMBL17660593

SCHEMBL17660593

CC(C)c1ccc(N2CCN(C3COC3)C[C@H]2C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.39
TLR8 Q9NR97 2/20 0.38
TLR7 Q9NYK1 2/20 0.38
EGFR P00533 2/20 0.37
BTK Q06187 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
MAP3K12 Q12852 1/20 0.35
JAK2 O60674 2/20 0.34
TBK1 Q9UHD2 2/20 0.34
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM2 P08172 2/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17660605 1.00 SLC18A3 (0.39) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL22296226 1.00 SLC18A3 (0.39) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL21679537 0.86 SLC18A3 (0.41) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL21679536 0.86 SLC18A3 (0.41) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL17642597 0.84 SLC18A3 (0.42) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL17665174 0.84 SLC18A3 (0.42) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL23865969 0.83 SLC18A3 (0.44) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL22296390 0.83 SLC18A3 (0.41) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL17642588 0.83 SLC18A3 (0.41) SLC18A3TLR8TLR7EGFRBTK
SCHEMBL14925508 0.81 TLR8 (0.40) TLR8TLR7EGFRBTKMAP3K12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10253019-B2 Tank-binding kinase inhibitor compounds GILEAD SCIENCES, INC. (US) 2019-04-09 US disclosed
US-10040781-B2 Tank-binding kinase inhibitor compounds GILEAD SCIENCES, INC. (US) 2018-08-07 US disclosed
US-10040781-B2 Tank-binding kinase inhibitor compounds GILEAD SCIENCES, INC. (US) 2018-08-07 US disclosed
US-20160096827-A1 TANK-BINDING KINASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253019-B2 Tank-binding kinase inhibitor compounds TBKBP1, TNKS1BP1, TNKS SLC18A3 4614/4885TLR8 3481/4885TLR7 3524/4885
US-10040781-B2 Tank-binding kinase inhibitor compounds TBKBP1, TNKS1BP1, TNKS SLC18A3 4614/4885TLR8 3481/4885TLR7 3524/4885
US-20160096827-A1 TANK-BINDING KINASE INHIBITOR COMPOUNDS TBKBP1, TNKS1BP1, TNKS SLC18A3 4614/4885TLR8 3481/4885TLR7 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.